Mesh Meta Analysis of Chinese Medicine for Fibromyalgia Syndrome

Objective: Provision of the clinical efficacy of different interventions for the treatment of fibromyalgia syndrome by mesh meta analysis method. Methods: Computer retrieval of the Chinese Internet Database (CNKI), VIP Database (VIP), Wanfang Database, Chinese Biomedical Documentation Database (CBM)), PubMed, Embase, Cochrane Library and other databases to collect and screen publicly published randomized controlled trials (RCT) related to the treatment of primary diseases of Chinese medicine; then extract the materials incorporated into the literature and perform biased risk evaluations of the inclusion literature through the biased evaluation criteria of Cochrane Handbook 5.1.0; and finally, the ADDIS 1.16.8 software for all low bias The treacherous high Results: 38 sections of literature involving 12 interventions, total 3143 cases of low risk literature, 24 of which mesh meta analysis showed: ① Needles in improving VAS pain scores. Oral + Western medicine and acreage line for Chinese medicine; ② Improve greater prevalence The highest probability of accretion line becoming the best treatment, followed by the combination of pick-up or acerbic cupping and western medicine; the best method in terms of improving FIQ score+Western drug treatment is likely to be the best intervention program, followed by accretion line; 4. Needling is the best treatment option for improving HAMD score. Conclusion: For The clinical efficacy of Chinese medicine in the treatment of fibromyalgia syndrome is better than Routine therapy alone, and comprehensive treatment programs are generally superior to single treatment programs, but due to the limitations of the literature and current research, the findings are yet to be further confirmed by more high-quality clinical randomized controlled trials in the future.